Status:
COMPLETED
Effect of Ondansetron for Withdrawal Symptoms
Lead Sponsor:
Stanford University
Conditions:
Substance Withdrawal Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
We hope to determine whether Ondansetron, an anti-nausea medication, works to help relieve withdrawal symptoms experienced while the patient is being weaned off opioid medications. This medication has...
Eligibility Criteria
Inclusion
- Over 18 years of age
- No medical contraindications to medication
- Able to fulfill research procedures
Exclusion
- Subjects who are unable to respond to our questionnaires or to stimuli as required by the experimental protocol will be excluded.
- Subjects will be excluded if they have a history of significant psychiatric disorders that would prevent them from engaging in a treatment program.
- Participating in other studies that would interfere with the procedures in this study
- Known or apparent pregnancy
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00695864
Start Date
May 1 2008
End Date
July 1 2009
Last Update
May 15 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305